SYNDICA RETATRUTIDE 40MG PEN ACE031 and glucagon-related pathways

and glucagon-related pathways

repeatable handling within laboratory environments

Keep securely stored until required for research

To maintain product stability and integrity:

Typically studied for tissue-response models

SYNDICA RETATRUTIDE 40MG PEN ACE031 and glucagon-related pathwaysThe Syndica Retatrutide 40mg Pen is a premium research grade formulation developed for advanced laboratory investigation into metabolic signalling, incretin pathway activity, appetite regulation mechanisms, and energy balance research. Retatrutide is widely studied as a next generation multi receptor agonist compound, with research interest focused on its interaction with GLP 1, GIP, and glucagon related pathways. This 40mg presentation is supplied in